Objectives: Efforts to control tuberculosis (TB) have been hampered by the emergence of multipledrug resistant strains, necessitating pursuit of alternative approaches to the current antibiotic-based treatments. Herein, we explore the feasibility of photodynamic inactivation (PDI) of mycobacteria.
Introduction
Tuberculosis (TB) is a significant health threat in the world today, with approximately one-third of the world's population currently infected, resulting in 9.2 million new infections and 1.7 million deaths reported for 2006 alone. 1 While a number of antibiotics (isoniazid, rifampicin, ethionamide) are effective against the causative agent Mycobacterium tuberculosis, a Gram-positive bacterium, the rise in multidrug-resistant (MDR) strains due to improper or incomplete drug therapy has increased dramatically. For 2006, the WHO reported the highest ever recorded global average of MDR-TB among newly detected TB cases at 5%, with areas in the former Soviet Union peaking at .20%. 1 These alarming numbers have sparked a new round of interest in the search for better and alternative anti-TB treatments.
Significant advances made in the past decade in treating several forms of cancer with photodynamic therapy (PDT) suggest that photodynamic inactivation (PDI) of localized bacterial infections such as TB might also be feasible, thus allowing for the development of a valuable alternative or supplemental option to the current antibiotic-based treatments. 2 PDI employs a localized, light-activated photosensitizer (PS) that generates cytotoxic species, particularly singlet oxygen, upon illumination with visible light. 3 Development of bacterial resistance to PDI is believed to be unlikely due to the non-specific damage caused by 1 O 2 . 4 The efficacy of PDI against Escherichia coli, Staphylococcus aureus (including methicillin-resistant strains), Acinetobacter baumannii and Pseudomonas aeruginosa has been discussed widely in the literature, 2 but fundamental in vitro studies on mycobacteria are still lacking. In light of this, we have examined the drug and light dose dependencies of several PSs on mycobacterial survival using Mycobacterium smegmatis mc 2 155, a widely employed non-pathogenic surrogate for M. tuberculosis.
Methods
M. smegmatis was grown in 5 mL cultures in Middlebrook 7H9 media with ADS and 100 mg/mL cycloheximide as the antibiotic. The cells were incubated at 378C on an orbital shaker until an optical density of 0.6-0.7 at 600 nm, corresponding to a concentration of 1-3Â10 8 cfu/mL, was reached. The cultures were then pelleted by centrifugation (10 min, 3716 g), the supernatant discarded, and the cells were resuspended in a total volume of 5 mL PBS (170 mM NaCl, 3.4 mM KCl, 10.0 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.2) containing 0.5% Tween-80 and the appropriate concentration of the PS. The cells were incubated for 5 min in the dark at 378C under agitation.
The PSs (see Figure 1 After illumination, 100 mL of the cell suspension was 1:10 serially diluted six times, plated on square plates (Middlebrook 7H10-ADS) and incubated at 378C in the dark for 40 h. The survival rate was determined from the ratio of cfu/mL of the illuminated solution and the dark control. Variations in the bacterial concentration of the starter cultures (1-4Â10 8 cfu/mL) resulted in a variation of the detection limit spanning the region of 0.001-0.0001% survival. Samples with PS present but kept in the dark (dark control) and illuminated samples without PS (light control) served as controls. All experiments were conducted in triplicate at a minimum, and statistical significance was assessed via a two-tailed, unpaired Student's t-test.
Results
The greatest extent of mycobacterial PDI was observed when employing cationic porphyrins 1 and 2 as the PSs (Figure 1 ). In the low micromolar concentration range, TMPyP (1) (Figure 2a ) reduced bacterial survival by 5-6 log units (99.999% þ viable cell eradication, P, 0.001), even after illumination times as short as 60 s. Excellent antimycobacterial activity was also observed for the pharmaceutically relevant concentration of 150 nM: 3, 4 and 5 -6 log unit reduction in viable cells after 5, 15 or 30 min illumination, respectively (P, 0.001). With TNMAP (2) (Figure 2b) , a maximum viable cell reduction of 3.5 log units (P, 0.001) occurred after 30 min illumination at 7.5 mM ($300-fold less efficient than with 1). However, 2 exhibited the lowest PS concentration (100 nM) for which antimycobacterial PDI was achievable (14% survival, 30 min illumination, P ¼ 0.001). The results obtained here for 1 and 2 are significantly better than the only other report of in vitro mycobacterial PDI (,2 log units reduction of Mycobacterium bovis BCG, 5 mM verteporfin as PS, 60 J/cm 2 , 690 nm). 5 In the presence of 2 -20 mM of the singlet oxygen quencher NaN 3 , a statistically significant increase in mycobacterial survival was observed for 1 [see Table S1 available as Supplementary data at JAC Online (http:// jac.oxfordjournals.org/)], suggesting that PDI of M. smegmatis is mediated in part by singlet oxygen production.
MB (3), a cationic phenothiazine, was effective only at the highest concentrations tested (Figure 2c ): a 4 log unit reduction in viable cells was observed after 30 min illumination at 75 mM (P,0.001), but this decreased to a 2 log unit reduction at 7.5 mM (P, 0.001). In general, the anionic PSs TSPP (4), TCPP-Pd (5) and PhCS (6) did not mediate any statistically significant (P. 0.05) PDI efficiently in the concentration range tested (Figure 2d -f ) , with the only exception being a 50% reduction in viable cells for TSPP at the highest concentration tested (P ¼ 0.02).
The degree of PS association (binding or uptake) to M. smegmatis was evaluated by fluorescence spectroscopy (Table 1) . 2 Consistent with its efficient PDI at 100 nM (Figure 2b ), TNMAP (2) exhibited the highest amount of PS recovered from lysed cells, suggesting a strong association with M. smegmatis. TMPyP (1) was found to bind to M. smegmatis to a lesser degree than 2, but a number of factors not related to binding, such as differences in photophysical properties, dye aggregation, localization and/or uptake, are likely reasons why 1 is overall the more efficient PS. MB (3) is the least able of the cationic PS to bind to M. smegmatis, which helps to rationalize the large difference in PDI mediated by 3 compared with 2 despite their similar quantum yields of singlet oxygen production [F D ; see Table S2 available 
Discussion
Our results demonstrate that cationic PSs can be potent photodynamic inactivators of mycobacteria, whereas anionic PSs exhibit little effect. Comparison of the PSs' photophysical properties alone, however, cannot be used to rationalize the observed differences in the extent of PDI mediated by each, as such properties may be significantly different within the mycobacterium cytoplasm, or at the cell surface where the PS may bind. A table of the photophysical properties of 1 -6, where known, is provided in the Supplementary data at JAC Online along with their relevant literature citations (Table S2) . For example, PS 1 possesses very favourable photophysical properties, with a quantum yield of singlet oxygen production (F D ) of 0.74, whereas PSs 2 and 3 exhibit a F D of $0.5, although our study shows that 2 appears to be significantly more effective against M. smegmatis. Among the anionic PSs, TSPP (4) also shows a favourable F D of 0.75, yet efficient inactivation of M. smegmatis was not observed with any anionic PS (4-6).
Looking beyond photophysical properties as the primary explanation for the observed mycobactericidal PDI effects, we hypothesize that PS binding may be the critical factor. Interestingly, cationic PSs have been reported to bind efficiently to both Figure 2 . PDI of M. smegmatis using PSs 1-6. The illumination time was varied over 1, 5, 15 and 30 min, corresponding to total fluences of 3.6, 18, 54 and 108 J/cm 2 , respectively, at 60 mW/cm 2 . Variations in the bacterial concentration of the starter cultures (1Â10 8 -4Â10 8 cfu/mL) resulted in a variation of the detection limit spanning the region of 0.001-0.0001% survival (shaded). As the plating technique employed did not allow for detection of survival rates of ,0.0001%, data points below the detection limit are set to 0.0001% survival for graphing purposes. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC. 
Feese and Ghiladi
Gram-positive as well as Gram-negative bacteria, 6 whereas anionic PSs are known to bind and photoinactivate only the former. 7 Although M. smegmatis is categorized as Gram-positive, our data unequivocally shows that it behaves in a similar fashion to a Gram-negative bacterium: cationic PSs were effective in mediating the PDI of M. smegmatis, anionic ones were clearly unable to do so. Although the extent of PS localization, aggregation, penetration across the mycobacterial membrane and retention (as well as the kinetics of such processes) are beyond the scope of this current study, our PS binding study strongly suggests that the localization and/or binding affinity of the PS to the mycobacterial cell is crucial for the efficacy of the PDI process, and suggests that rapid fluorescence binding assays may be used as an initial screening tool for future PS development.
Recently, O'Riordan et al. 5, 8 investigated the in vivo susceptibility of localized M. bovis BCG-induced granulomatous infections in murine models towards PDI. Their results showed promise, with a 1-2 log unit reduction in viable cells. However, the PS employed in that study, verteporfin (an anionic porphyrin) and two phenothiazine derivatives (weakly cationic and similar to MB, 3), would be predicted by our present study as being non-ideal (in hindsight) candidates for mediating PDI inactivation of mycobacteria due to their poor ability to associate with the negatively charged cell surface. Thus, we conclude that future in vivo studies on utilizing PDI to clear mycobacterial infections should focus on the use of highly cationic PSs, with the caveat that other factors such as compound lipophilicity, aggregation or localization also need to be considered.
The results reported herein detail the first fundamental in vitro survey of mycobacterial PDI using a range of PS types, concentrations and light doses, and provides the necessary foundation work to help direct future in vivo studies. We have observed the greatest extent of mycobacterial cell inactivation (up to 6 log units) reported to date, while maintaining excellent photodynamic conditions of short illumination times and extremely low (nM) PS concentrations. Our data also indicate that highly charged cationic PSs should be employed against Gram-positive mycobacteria, as association with the mycobacterial cell appears to be the primary factor in cell inactivation, albeit moderate to good photophysical properties play a contributing role. With the ongoing development of fibreoptic-based PDT to treat lung tumours and small-cell carcinomas, 9 PDI of adult pulmonary TB might potentially be an attractive alternative treatment option, particularly for MDR-TB where cost-efficient antibiotics are ineffective, or when a need for rapidly reducing bacterial load is required. Photodynamic inactivation of M. smegmatis
